C. diff. Spores and More

Our guests from Seres Therapeutics shared the latest news

on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The study results were equally compelling when characterized by the alternative metric of sustained clinical response, where 88.9% of patients in the SER-109 arm achieved this objective. The study’s efficacy results exceeded the statistical threshold previously provided in consultation with the U.S. Food and Drug Administration (FDA) that could allow this single clinical study to fulfill efficacy requirements for a Biologics License Application (BLA). The SER-109 safety results were favorable, with an adverse event profile comparable to a placebo. Listen in and learn more from the leading topic experts.

Join our guests, Missy Travis, RN, and Priya Balachandran, Ph. D. COO Applied Silver,

as they discuss the role of cleaning and disinfection to prevent surface contamination leading to the transmission of infections, There are also new concerns about CDI given the current state of COVID-19 and our guests will discuss this topic in great detail.

What are your thoughts about linens and pathogens? Missy Travis, RN, and

Dr. Balachandran will be sharing innovative solutions that maintain infection prevention in an array of settings.

Join us with our guest, Irwin Stromeyer, Owner, Sterile Space Infection Defense, LLC

Irwin Stromeyer is an industry leader in the public infection prevention arena. He had been speaking about the current twin-demic’ of COVID and FLU.

Join our guests, Missy Travis, RN, and Priya Balachandran, Ph. D. COO Applied Silver,

as they discuss the role of cleaning and disinfection to prevent surface contamination leading to the transmission of infections, There are also new concerns about CDI given the current state of COVID-19 and our guests will discuss this topic in great detail.

What are your thoughts about linens and pathogens? Missy Travis, RN, and

Dr. Balachandran will be sharing innovative solutions that maintain infection prevention in an array of settings.

Join us with our guest, Ron Roman, RN, CEO Safety Net as we discuss creating a safe environment, maintaining a safe environment in both healthcare and home. Ron will review Disinfection – what is Clean, Sanitize, Disinfect and Sterilize and how to simplify the terms.

Join us as guests Sue Barnes, RN, BSN, CIC, FAPIC, Independent and Board Certified Clinical Consultant in Infection Control and Prevention and APIC Fellow with Lori Strazdas, MPH - Public Health Liaison with Clorox Healthcare discuss the importance of C. difficile and how difficult of an infection it is to manage not only for patients but for the caretakers and loved ones. Before the patient leaves the hospitals, it is critical to understand the proper steps to reduce the spread of C. difficile spores in the home environment. In this episode, learn why it is important to focus on the home environment during and after a C. difficile infection and what can be done to reduce the risk of transmission and recurrence. Our guests will be discussing the types of disinfecting products that can be utilized to effectively kill C. diff. spores and how to use the products properly to accomplish this in the home environment.

Join us with our guests from Seres Therapeutics as they discuss the latest news

on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C.

This is a Special Presentation: Join us with our three brave guests as they take a step forward to share their C. difficile infection journey and deliver a personal message with our global listeners.

It's NOT Just Diarrhea.

Join us with our guest

James Boone, M.S., as we discuss

Inflammatory Bowel Disease patients who are highly susceptible to

C. difficile infections. The two diseases have similar symptoms, but very different treatments. This segment will examine the diagnostic methods which can distinguish between inflammatory bowel disease and C. difficile infection, discuss testing guidelines, and touch upon recent clinical research and advances.

Join us with our guest, Professor Simon Cutting, Ph. D., as we discuss

the genetic control of spore formation in Bacillus subtilis, and the research behind the scenes defining Clostridioides difficile in health and environment.